Clinical Trial Update: Phase III Study of GSK1278863 in Japanese Non-dialysis (ND) and Peritoneal Dialysis (PD) Subjects With Renal Anemia [Phase 3]

View source ↗

Summary

Phase III study of GSK1278863 in Japanese non-dialysis and peritoneal dialysis patients with renal anemia has completed; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Renal Anemia

Drugs mentioned

• GSK1278863

Snippet

Sponsor: GlaxoSmithKline | Conditions: Anaemia | Phase 3 | Status: COMPLETED | Results posted: 2019-11-13